Compile Data Set for Download or QSAR
maximum 50k data
Found 56 Enz. Inhib. hit(s) with Target = 'Trypsinogen 16'
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193350(US9199927, 61)
Affinity DataIC50:  0.140nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193349(US9199927, 108 | US9199927, 60)
Affinity DataIC50:  0.140nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193317(US9199927, 28)
Affinity DataIC50:  0.170nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193313(US9199927, 24)
Affinity DataIC50:  0.170nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193351(US9199927, 62)
Affinity DataIC50:  0.170nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193310(US9199927, 21)
Affinity DataIC50:  0.170nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193315(US9199927, 26)
Affinity DataIC50:  0.180nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193290(US9199927, 1)
Affinity DataIC50:  0.190nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193319(US9199927, 30)
Affinity DataIC50:  0.190nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193316(US9199927, 27)
Affinity DataIC50:  0.190nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193304(US9199927, 15)
Affinity DataIC50:  0.190nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193311(US9199927, 22)
Affinity DataIC50:  0.200nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193349(US9199927, 108 | US9199927, 60)
Affinity DataIC50:  0.210nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193318(US9199927, 29)
Affinity DataIC50:  0.210nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193303(US9199927, 14)
Affinity DataIC50:  0.220nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193360(US9199927, 71)
Affinity DataIC50:  0.230nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193323(US9199927, 34)
Affinity DataIC50:  0.240nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193314(US9199927, 25)
Affinity DataIC50:  0.25nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193305(US9199927, 16)
Affinity DataIC50:  0.260nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193306(US9199927, 17)
Affinity DataIC50:  0.270nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193312(US9199927, 23)
Affinity DataIC50:  0.280nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193395(US9199927, 113)
Affinity DataIC50:  0.280nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193324(US9199927, 35)
Affinity DataIC50:  0.280nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193369(US9199927, 80)
Affinity DataIC50:  0.300nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193415(US9199927, 102)
Affinity DataIC50:  0.300nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193348(US9199927, 59)
Affinity DataIC50:  0.310nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193330(US9199927, 41)
Affinity DataIC50:  0.310nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193326(US9199927, 37)
Affinity DataIC50:  0.340nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193320(US9199927, 31)
Affinity DataIC50:  0.340nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193342(US9199927, 53)
Affinity DataIC50:  0.350nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193325(US9199927, 36)
Affinity DataIC50:  0.380nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193343(US9199927, 54)
Affinity DataIC50:  0.380nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193367(US9199927, 78)
Affinity DataIC50:  0.390nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193383(US9199927, 94)
Affinity DataIC50:  0.390nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193341(US9199927, 52)
Affinity DataIC50:  0.390nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193417(US9199927, 131)
Affinity DataIC50:  0.400nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193352(US9199927, 63)
Affinity DataIC50:  0.410nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193393(US9199927, 111)
Affinity DataIC50:  0.440nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193301(US9199927, 11)
Affinity DataIC50:  0.450nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193329(US9199927, 40)
Affinity DataIC50:  0.450nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193354(US9199927, 65)
Affinity DataIC50:  0.450nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193355(US9199927, 66)
Affinity DataIC50:  0.450nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193414(US9199927, 96)
Affinity DataIC50:  0.460nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193340(US9199927, 51)
Affinity DataIC50:  0.470nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193291(US9199927, 2)
Affinity DataIC50:  0.490nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193309(US9199927, 20)
Affinity DataIC50:  0.540nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193382(US9199927, 93)
Affinity DataIC50:  0.560nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193322(US9199927, 33)
Affinity DataIC50:  0.600nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193345(US9199927, 56)
Affinity DataIC50:  0.640nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma

US Patent
LigandPNGBDBM193413(US9199927, 95)
Affinity DataIC50:  0.640nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 56 total ) | Next | Last >>
Jump to: